Alpha Cognition Income After Taxes 2020-2024 | ACOG
Alpha Cognition income after taxes from 2020 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Alpha Cognition Annual Income After Taxes
(Millions of US $) |
| 2023 |
$-14 |
| 2022 |
$-12 |
| 2021 |
$-20 |
| 2020 |
$-6 |
| 2019 |
$-7 |
Alpha Cognition Quarterly Income After Taxes
(Millions of US $) |
| 2024-06-30 |
$-2 |
| 2024-03-31 |
$-5 |
| 2023-12-31 |
$-6 |
| 2023-09-30 |
$-3 |
| 2023-06-30 |
$-3 |
| 2023-03-31 |
$-2 |
| 2022-12-31 |
$-4 |
| 2022-09-30 |
$-2 |
| 2022-06-30 |
$-3 |
| 2022-03-31 |
$-3 |
| 2021-12-31 |
$-3 |
| 2021-09-30 |
$-4 |
| 2021-06-30 |
$0 |
| 2021-03-31 |
$-12 |
| 2020-12-31 |
$-2 |
| 2020-09-30 |
$-1 |
| 2020-06-30 |
$-2 |
| 2020-03-31 |
$-1 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
